MicroRNA-103a-3p controls proliferation and osteogenic differentiation of human adipose tissue-derived stromal cells

Experimental and Molecular Medicine

Volumn 47, Issue 7, 2015, Pages

  Kim, Da Sol ^a   Lee, Sun Young ^a   Lee, Jung Hee ^a   Bae, Yong Chan ^a   Jung, Jin Sup ^a  

^a Pusan National University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 6; DEAD BOX PROTEIN; DICER1 PROTEIN, HUMAN; MICRORNA; MIRN103 MICRORNA, HUMAN; RIBONUCLEASE III;

ADIPOSE TISSUE; BONE DEVELOPMENT; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; STROMA CELL;

ADIPOSE TISSUE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE 6; DEAD-BOX RNA HELICASES; GENE EXPRESSION REGULATION; HUMANS; MICRORNAS; OSTEOGENESIS; RIBONUCLEASE III; STROMAL CELLS;

EID: 85018228486     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.1038/EMM.2015.39     Document Type: Article

References (43)

1. Huntzinger E, Izaurralde E. Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat Rev Genet 2011; 12: 99–110.
2. Shi XE, Li YF, Jia L, Ji HL, Song ZY, Cheng J et al. MicroRNA-199a-5p affects porcine preadipocyte proliferation and differentiation. Int J Mol Sci 2014; 15: 8526–8538.
3. Schober A, Nazari-Jahantigh M, Wei YY, Bidzhekov K, Gremse F, Grommes J et al. MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1. Nat Med 2014; 20: 368–376.
4. Hong Z, Feng Z, Sai Z, Tao S. PER3, a novel target of miR-103, plays a suppressive role in colorectal cancer in vitro. BMB Rep 2014; 47: 500–505.
5. Ukai T, Sato M, Akutsu H, Umezawa A, Mochida J. MicroRNA-199a-3p, microRNA-193b, and microRNA-320c are correlated to aging and regulate human cartilage metabolism. J Orthop Res 2012; 30: 1915–1922.
6. Cairo S, Wang Y, de Reynies A, Duroure K, Dahan J, Redon MJ et al. Stem cell-like micro-RNA signature driven by Myc in aggressive liver cancer. Proc Natl Acad Sci USA 2010; 107: 20471–20476.
7. Liu T, Chen Q, Huang Y, Huang Q, Jiang L, Guo L. Low microRNA-199a expression in human amniotic epithelial cell feeder layers maintains human-induced pluripotent stem cell pluripotency via increased leukemia inhibitory factor expression. Acta Biochim Biophys Sin (Shanghai) 2012; 44: 197–206.
8. Liu X, He M, Hou Y, Liang B, Zhao L, Ma S et al. Expression profiles of microRNAs and their target genes in papillary thyroid carcinoma. Oncol Rep 2013; 29: 1415–1420.
9. Boren T, Xiong Y, Hakam A, Wenham R, Apte S, Wei Z et al. MicroRNAs and their target messenger RNAs associated with endometrial carcinogen-esis. Gynecol Oncol 2008; 110: 206–215.
10. Wang HY, Yan LX, Shao Q, Fu S, Zhang ZC, Ye W et al. Profiling plasma microRNA in nasopharyngeal carcinoma with deep sequencing. Clin Chem 2014; 60: 773–782.
11. Chakraborty C, George Priya Doss C, Bandyopadhyay S. miRNAs in insulin resistance and diabetes-associated pancreatic cancer: the 'minute and miracle' molecule moving as a monitor in the 'genomic galaxy'. Curr Drug Targets 2013; 14: 1110–1117.
12. Scheffer AR, Holdenrieder S, Kristiansen G, von Ruecker A, Muller SC, Ellinger J. Circulating microRNAs in serum: novel biomarkers for patients with bladder cancer? World J Urol 2014; 32: 353–358.
13. Zhu X, Zhang X, Wang H, Song Q, Zhang G, Yang L et al. MTA1 gene silencing inhibits invasion and alters the microRNA expression profile of human lung cancer cells. Oncol Rep 2012; 28: 218–224.
14. Geng L, Sun B, Gao B, Wang Z, Quan C, Wei F et al. MicroRNA-103 promotes colorectal cancer by targeting tumor suppressor DICER and PTEN. Int J Mol Sci 2014; 15: 8458–8472.
15. Trajkovski M, Hausser J, Soutschek J, Bhat B, Akin A, Zavolan M et al. MicroRNAs 103 and 107 regulate insulin sensitivity. Nature 2011; 474: 649–653.
16. Liao Y, Lonnerdal B. Global microRNA characterization reveals that miR-103 is involved in IGF-1 stimulated mouse intestinal cell proliferation. PLoS One 2010; 5: e12976.
17. Wilfred BR, Wang WX, Nelson PT. Energizing miRNA research: a review of the role of miRNAs in lipid metabolism, with a prediction that miR-103-/107 regulates human metabolic pathways. Mol Genet Metab 2007; 91: 209–217.
18. Zuk P. Adipose-derived stem cells in tissue regeneration: a review. ISRN Stem Cells 2013; 2013: 1–35.
19. Shin KK, Kim YS, Kim JY, Bae YC, Jung JS. miR-137 controls proliferation and differentiation of human adipose tissue stromal cells. Cell Physiol Biochem 2014; 33: 758–768.
20. Kim YJ, Hwang SJ, Bae YC, Jung JS. MiR-21 regulates adipogenic differentiation through the modulation of TGF-beta signaling in mesench-ymal stem cells derived from human adipose tissue. Stem Cells 2009; 27: 3093–3102.
21. Kim YJ, Bae SW, Yu SS, Bae YC, Jung JS. miR-196a regulates proliferation and osteogenic differentiation in mesenchymal stem cells derived from human adipose tissue. J Bone Miner Res 2009; 24: 816–825.
22. Kim Y, Kim H, Cho H, Bae Y, Suh K, Jung J. Direct comparison of human mesenchymal stem cells derived from adipose tissues and bone marrow in mediating neovascularization in response to vascular ischemia. Cell Physiol Biochem 2007; 20: 867–876.
23. Dweep H, Sticht C, Pandey P, Gretz N.. miRWalk–database: prediction of possible miRNA binding sites by ‘walking’ the genes of three genomes. JBiomedInform2011; 44: 839–847.
24. Annibali D, Gioia U, Savino M, Laneve P, Caffarelli E, Nasi S. A new module in neural differentiation control: two microRNAs upregulated by retinoic acid, miR-9 and-103, target the differentiation inhibitor ID2. PLoS One 2012; 7: e40269.
25. Meyerson M, Enders GH, Wu CL, Su LK, Gorka C, Nelson C et al. Afamily of human cdc2-related protein kinases. EMBO J 1992; 11: 2909–2917.
26. Grossel MJ, Hinds PW.. From cell cycle to differentiation: an expanding role for cdk6. Cell Cycle 2006; 5: 266–270.
27. Kikkawa N, Kinoshita T, Nohata N, Hanazawa T, Yamamoto N, Fukumoto I et al. microRNA-504 inhibits cancer cell proliferation via targeting CDK6 in hypopharyngeal squamous cell carcinoma. Int J Oncol 2014; 44: 2085–2092.
28. Moro T, Ogasawara T, Chikuda H, Ikeda T, Ogata N, Maruyama Z et al. Inhibition of Cdk6 expression through p38 MAP kinase is involved in differentiation of mouse prechondrocyte ATDC5. JCellPhysiol2005; 204: 927–933.
29. Zhu X, Li Y, Shen H, Li H, Long L, Hui Let al. miR-137 inhibits the proliferation of lung cancer cells by targeting Cdc42 and Cdk6. FEBS Lett 2013; 587: 73–81.
30. Chen L, Holmstrom K, Qiu W, Ditzel N, Shi K, Hokland L et al. MicroRNA-34a inhibits osteoblast differentiation and in vivo bone formation of human stromal stem cells. Stem Cells 2014; 32: 902–912.
31. Kaneko H, Dridi S, Tarallo V, Gelfand BD, Fowler BJ, Cho WG et al. DICER1 deficit induces Alu RNA toxicity in age-related macular degeneration. Nature 2011; 471: 325–330.
32. Luense LJ, Carletti MZ, Christenson LK. Role of Dicer in female fertility. Trends Endocrinol Metab 2009; 20: 265–272.
33. Kanji MS, Martin MG, Bhushan A. Dicer1 is required to repress neuronal fate during endocrine cell maturation. Diabetes 2013; 62: 1602–1611.
34. Oskowitz AZ, Penfornis P, Tucker A, Prockop DJ, Pochampally R. Drosha regulates hMSCs cell cycle progression through a miRNA independent mechanism. Int J Biochem Cell Biol 2011; 43: 1563–1572.
35. Bai Y, Qiu GR, Zhou F, Gong LY, Gao F, Sun KL. Overexpression of DICER1 induced by the upregulation of GATA1 contributes to the proliferation and apoptosis of leukemia cells. Int J Oncol 2013; 42: 1317–1324.
36. Feinberg-Gorenshtein G, Guedj A, Shichrur K, Jeison M, Luria D, Kodman Y et al. MiR-192 directly binds and regulates Dicer1 expression in neuro-blastoma. PLoS One 2013; 8: e78713.
37. Gaur T, Hussain S, Mudhasani R, Parulkar I, Colby JL, Frederick D et al. Dicer inactivation in osteoprogenitor cells compromises fetal survival and bone formation, while excision in differentiated osteoblasts increases bone mass in the adult mouse. Dev Biol 2010; 340: 10–21.
38. Kaneshiro S, Ebina K., Shi K, Higuchi C, Hirao M, Okamoto M et al. IL-6 negatively regulates osteoblast differentiation through the SHP2/MEK2 and SHP2/Akt2 pathways in vitro. J Bone Miner Metab 2014; 32: 378–392.
39. Suzuki D, Yamada A, Aizawa R, Funato S, Matsumoto T, Suzuki W et al. BMP2 differentially regulates the expression of Gremlin1 and Gremlin2, the negative regulators of BMP function, during osteoblast differentiation. Calcif Tissue Int 2012; 91: 88–96.
40. Ahmed FE, Ahmed NC, Vos PW, Bonnerup C, Atkins JN, Casey M et al. Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle. Cancer Genomics Proteomics 2013; 10: 93–113.
41. Wang X, Guo B, Li Q, Peng J, Yang Z, Wang A et al. miR-214 targets ATF4 to inhibit bone formation. Nat Med 2013; 19: 93–100.
42. Zhang YH, Shen L, Shen Y, Chen XD, Jiang LS. Study on key genes and regulatory networks associated with osteoporosis by microarray technology. Genet Test Mol Biomarkers 2013; 17: 625–630.
43. Kim JH, Lee MR, Kim JH, Jee MK, Kang SK. Retraction: 'IFATS collection: selenium induces improvement of stem cell behaviors in human adipose-tissue stromal cells via SAPK/JNK and stemness acting signals'. Stem Cells 2013; 31: 2848.